A virus is a copying machine
A virus cannot copy itself alone. It must get inside a living cell and borrow that cell’s machinery. Once inside, it makes copy after copy after copy.
Every copy is a chance for a mistake. A mistake in the genetic code is a mutation. Most mutations do nothing useful. A few change the virus in ways that matter.
This is ordinary evolution. It is just running very, very fast.
Why RNA viruses mutate so fast
Influenza and SARS-CoV-2 store their genes in RNA rather than DNA. Three things then work together.
The copying is sloppy. Your cells copy DNA with a proofreading step. It finds and fixes most errors. The enzyme that copies flu RNA has no proofreading step at all.
Measured rates for RNA viruses come out at roughly 0.03 to 2 new mistakes in the whole genome every time it is copied. In plain terms, a new virus particle often differs from its parent by a letter or two. Your own cells make errors far more rarely than that.
The numbers are enormous. A single infected person can carry billions of virus particles. When copying happens that many times, even a rare error is almost certain to appear somewhere.
The generations are short. New virus particles can be made within hours. A flu virus can pass through more generations in one week inside one person than a human family passes through in a thousand years.
Sloppy copying, huge numbers, and short generations are the three ingredients of fast evolution. Viruses have all three.
There is one interesting exception. Coronaviruses, including SARS-CoV-2, carry a protein called nsp14 that acts as a proofreader and removes some wrong letters. That makes them slower mutators than flu. It did not save us from variants, and the reason why is worth understanding.
Antigenic drift: the small yearly change
Flu viruses are studded with two surface proteins. One is hemagglutinin, usually shortened to HA. The other is neuraminidase, or NA. The H and the N in a name like H3N2 come from those two proteins.
Your immune system learns the shape of HA and NA. It builds antibodies that lock onto them and block the virus.
Now add mutation. Small changes keep nudging the shape of HA and NA a little at a time. The CDC calls this antigenic drift. Each single change is minor. Season after season, the changes stack up.
Eventually the surface has drifted far enough that antibodies trained on last year’s flu no longer grip it well. The virus slips past defenses that used to work.
That is why you can catch flu again and again through your life, and why the vaccine cannot be built once and left alone.
Antigenic shift: the rare big jump
Influenza A has a second trick, and it is a strange one. Its genome is not a single strand. It is split into eight separate segments.
If two different flu viruses infect the same cell at the same time, the segments can be mixed and repackaged. A pig, for example, can be infected by a bird flu and a human flu at once. The virus that comes out may carry an HA protein that almost no human immune system has ever met.
That is antigenic shift. It is a sudden, major change rather than a slow one.
Shift is rare. It is also how flu pandemics begin. The pandemics of 1918, 1957, 1968 and 2009 all involved influenza A viruses that were new to most people. The 2009 H1N1 pandemic virus carried a mix of genes with pig, bird and human flu ancestry.
A useful way to remember it: drift is a slow edit to the cover of a book. Shift is a whole new cover.
Why the flu vaccine is rebuilt every year
Because flu drifts, the vaccine has to chase it. That chase is organized, and it happens ahead of time.
The World Health Organization runs a global surveillance network. Laboratories in many countries collect flu viruses from patients all year and send the data in. Twice a year, WHO holds a consultation and recommends what the next vaccine should contain. The meeting for the northern hemisphere is held in February. The meeting for the southern hemisphere is held in September.
Each country then decides for itself. In the United States, the Food and Drug Administration makes the final call for domestic vaccines, usually in February or March.
Recent United States flu vaccines are trivalent. That means they contain three components: an influenza A(H1N1) virus, an influenza A(H3N2) virus, and an influenza B virus from the Victoria lineage.
Notice the timing problem. The decision is made in late winter. The vaccine reaches people the following autumn. Manufacturing takes months, so the choice must be a forecast, not a report.
Some years the forecast is very good. Some years the circulating viruses drift after the decision is made, and the match is weaker. That is not a failure of the science. It is what happens when you have to predict the direction of an evolving population several months in advance.
Evolution watched live: SARS-CoV-2
The COVID-19 pandemic was the first time humans watched a virus evolve at global scale, almost in real time. Millions of viral genome sequences were shared publicly. Scientists could see new lineages rise and fall week by week.
Alpha was identified in Britain in late 2020 and spread faster than the versions before it. Delta was identified in India and drove severe waves through 2021. Then, on 26 November 2021, WHO named a new variant of concern: Omicron.
Omicron carried an unusual number of changes. WHO’s first technical brief counted roughly 26 to 32 of them in the spike protein alone. The spike is the knob the virus uses to enter cells, and it is the main target of our antibodies. Omicron swept the world within weeks.
Remember that SARS-CoV-2 has a proofreader and mutates more slowly than flu. It still produced all of that in about two years. The reason is scale. Hundreds of millions of infections, each making billions of copies, add up to an astronomical number of chances. A low error rate multiplied by a gigantic number of copies still gives you plenty of mutations.
Mutation is random. Spreading is not.
This is the single most important idea on this page, and it is easy to get backwards.
Mutations happen by accident. The virus is not trying to escape a vaccine, and it does not know a vaccine exists. It has no goals at all.
But what happens next is not random. A change that lets the virus infect cells more easily, or copy itself faster, or slip past existing antibodies, gets passed to more descendants. A change that makes the virus worse at any of that disappears. Out of a huge cloud of random changes, the ones that spread well are the ones we end up naming.
So the pattern looks purposeful, and it is not. It is natural selection acting on mutation, exactly as it does in antibiotic resistance.
The measles contrast
If viruses always outrun vaccines, the measles vaccine should have failed long ago. It has not. The vaccine first used in the 1960s still works.
Measles virus is an RNA virus, and it does mutate. Scientists have named about two dozen genotypes of it. A genotype is a group defined by its DNA sequence. But all of those genotypes still belong to a single serotype, which is a group the immune system cannot tell apart. Antibodies trained on one measles virus still recognize all the others.
Why the difference? Measles enters cells through a very narrow doorway. It uses particular docking points on the cell surface, called receptors, including one named CD150 on certain immune cells and one named nectin-4 on airway cells. The virus’s surface proteins have to keep fitting those receptors exactly.
Antibodies also grab several parts of those proteins at once, not just one spot. So a change that hides the virus from antibodies usually breaks its ability to get into cells at the same time.
Flu can afford to redecorate its surface. Measles cannot. Same process, different constraints, very different result.
That contrast is genuinely useful. It shows that “viruses evolve” does not mean “vaccines stop working.” Whether a vaccine needs updating depends on how much freedom that particular virus has to change.
The takeaway
Viruses are the clearest everyday example of evolution most of us will ever meet.
Flu drifts, so the vaccine is rebuilt every year from fresh surveillance data. Influenza A can also shift, which is how pandemics start. SARS-CoV-2 mutates slowly for an RNA virus, but infected so many people that variants appeared anyway. Measles mutates too, yet cannot escape its own vaccine, because its surface is locked in by the job it has to do.
None of these viruses is trying to do anything. They are copied, they make mistakes, and the versions that spread best become the versions we see.
If you want the underlying mechanism, read natural selection. If you want another example measured in hospitals every year, read antibiotic resistance.